Kiran Chaturvedi
Overview
Explore the profile of Kiran Chaturvedi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
183
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Deshmukh A, Chauhan P, Noolvi M, Chaturvedi K, Ganguly K, Shukla S, et al.
Int J Pharm
. 2017 Sep;
532(1):249-268.
PMID: 28882486
Rapidly developing polymeric micelles as potential targeting carriers has intensified the need for better understanding of the underlying principles related to the selection of suitable delivery materials for designing, characterizing,...
2.
Nema N, Kumar R, Verma A, Verma S, Chaturvedi K
Natl Med J India
. 2017 Aug;
30(2):73-75.
PMID: 28816213
Background: Presenile cataract is commonly idiopathic in origin. However, patients with presenile cataract could have an underlying genetic abnormality of galactose metabolism. We studied the association, if any, between idiopathic...
3.
Chaturvedi K, Ganguly K, Kulkarni A, Rudzinski W, Krauss L, Nadagouda M, et al.
Nanomedicine (Lond)
. 2015 May;
10(10):1569-83.
PMID: 26008194
Aim: To develop insulin loaded deoxycholic acid conjugated PEGylated polyhydroxybutyrate co-polymeric nanoparticles and carry out in vitro and in vivo testing of enteric coated granules comprising these nanoparticles. Materials &...
4.
Ganguly K, Chaturvedi K, More U, Nadagouda M, Aminabhavi T
J Control Release
. 2014 May;
193:162-73.
PMID: 24845128
Increased interest in developing novel micro/nanohydrogel based formulations for delivering macromolecular therapeutics has led to multiple choices of biodegradable and biocompatible natural polymers. This interest is largely due to the...
5.
Chaturvedi K, Ganguly K, Nadagouda M, Aminabhavi T
J Control Release
. 2012 Nov;
165(2):129-38.
PMID: 23159827
The search for an effective and reliable oral insulin delivery system has been a major challenge facing pharmaceutical scientists for over many decades. Even though innumerable carrier systems that protect...
6.
Chaturvedi K, Tripathi S, Kulkarni A, Aminabhavi T
J Microencapsul
. 2012 Oct;
30(4):356-68.
PMID: 23078151
Pharmacokinetics, biodistribution and antitumour activity of 5-fluorouracil (5-FU)-loaded polyhydroxybutyrate (PHB) and cellulose acetate phthalate (CAP) blend microspheres were investigated in chemically induced colorectal cancer in albino male Wistar rats and...
7.
Chaturvedi K, Ganguly K, Kulkarni A, Kulkarni V, Nadagouda M, Rudzinski W, et al.
Expert Opin Drug Deliv
. 2011 Aug;
8(11):1455-68.
PMID: 21867463
Introduction: The discovery of synthetic small interfering RNA (siRNA) has led to a surge of interest in harnessing RNA interference (RNAi) technology for biomedical applications and drug development. Even though...
8.
Chaturvedi K, Umadevi S, Vaghani S
Sci Pharm
. 2010 Dec;
78(4):927-39.
PMID: 21179326
Gastroretentive tablets of propranolol hydrochloride were developed by direct compression method using citric acid and sodium bicarbonate as the effervescent base. Hydroxypropyl methylcellulose; HPMC K15M was used to prepare the...
9.
Vaghani S, Vasanti S, Chaturvedi K, Satish C, Jivani N
Pharm Dev Technol
. 2010 Mar;
15(2):154-61.
PMID: 20214502
A multiple-unit-type oral floating dosage form (FDF) of 5-Fluorouracil (5-FU) was developed to prolong gastric residence time for the treatment of stomach cancer. The floating microspheres were prepared by solvent...
10.
Galandiuk S, Chaturvedi K, Topor B
Recent Results Cancer Res
. 2005 May;
165:21-9.
PMID: 15865017
Even though the technique of total mesorectal excision has been widely used, there have been few detailed descriptions of the distribution of lymph nodes within the rectal mesentery. We describe...